| A new antibiotic selectively kills Gram-negative pathogens Y Imai, KJ Meyer, A Iinishi, Q Favre-Godal, R Green, S Manuse, M Caboni, ... Nature 576 (7787), 459-464, 2019 | 804 | 2019 |
| High Yield Production Process for Shigella Outer Membrane Particles F Berlanda Scorza, AM Colucci, L Maggiore, S Sanzone, O Rossi, ... PloS one 7 (6), e35616, 2012 | 189 | 2012 |
| An O Antigen Capsule Modulates Bacterial Pathogenesis in Shigella sonnei M Caboni, T Pedron, O Rossi, D Goulding, D Pickard, F Citiulo, ... PLoS pathogens 11 (3), e1004749, 2015 | 124 | 2015 |
| Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in … O Rossi, I Pesce, C Giannelli, S Aprea, M Caboni, F Citiulo, S Valentini, ... Journal of Biological Chemistry 289 (36), 24922-24935, 2014 | 113 | 2014 |
| Down‐regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes G Lo Sasso, N Celli, M Caboni, S Murzilli, L Salvatore, A Morgano, ... Hepatology 51 (4), 1334-1344, 2010 | 104 | 2010 |
| Toll-like receptor activation by generalized modules for membrane antigens from lipid A mutants of Salmonella enterica serovars Typhimurium and Enteritidis O Rossi, M Caboni, A Negrea, F Necchi, R Alfini, F Micoli, A Saul, ... Clinical and Vaccine Immunology 23 (4), 304-314, 2016 | 101 | 2016 |
| Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella G De Benedetto, R Alfini, P Cescutti, M Caboni, L Lanzilao, F Necchi, ... Vaccine 35 (3), 419-426, 2017 | 85 | 2017 |
| A selective antibiotic for Lyme disease N Leimer, X Wu, Y Imai, M Morrissette, N Pitt, Q Favre-Godal, A Iinishi, ... Cell 184 (21), 5405-5418. e16, 2021 | 75 | 2021 |
| Cranberry extracts promote growth of Bacteroidaceae and decrease abundance of Enterobacteriaceae in a human gut simulator model K O’Connor, M Morrissette, P Strandwitz, M Ghiglieri, M Caboni, H Liu, ... PLoS One 14 (11), e0224836, 2019 | 49 | 2019 |
| A distinct microbiome signature in posttreatment Lyme disease patients M Morrissette, N Pitt, A González, P Strandwitz, M Caboni, AW Rebman, ... MBio 11 (5), 10.1128/mbio. 02310-20, 2020 | 31 | 2020 |
| Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data MK Chung, M Caboni, P Strandwitz, A D'Onofrio, K Lewis, CJ Patel eBioMedicine, 2023 | 17 | 2023 |
| An in vitro intestinal model captures immunomodulatory properties of the microbiota in inflammation JY Lock, M Caboni, P Strandwitz, M Morrissette, K DiBona, BA Joughin, ... Gut Microbes 14 (1), 2039002, 2022 | 7 | 2022 |
| Author Correction: a new antibiotic selectively kills Gram-negative pathogens Y Imai, KJ Meyer, A Iinishi, Q Favre-Godal, R Green, S Manuse, M Caboni, ... Nature 580 (7802), E3-E3, 2020 | 6 | 2020 |
| The making of a pathogen K Lewis, M Caboni Cell Host & Microbe 21 (6), 653-654, 2017 | 4 | 2017 |
| A distinct microbiome signature in posttreatment Lyme disease patients. mBio 11: e02310-20 M Morrissette, N Pitt, A González, P Strandwitz, M Caboni, AW Rebman, ... | 3 | 2020 |
| Identification and characterization of a capsule in Shigella and its role in the pathogenesis M Caboni unina, 2013 | 2 | 2013 |
| Therapeutic compositions and methods of using serotonin modulating microbiome-based interventions to treat serotonin-related diseases or disorders P STRANDWITZ, M CABONI, S Skolnick US Patent App. 18/816,824, 2025 | | 2025 |
| Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the US with administrative claims data (vol 90, 104524, 2023) MK Chung, M Caboni, P Strandwitz, A D'Onofrio, K Lewis, CJ Patel EBIOMEDICINE 93, 2023 | | 2023 |
| Corrigendum to “Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the US with administrative claims data” MK Chung, M Caboni, P Strandwitz, A D'Onofrio, K Lewis, CJ Patel EBioMedicine 93, 2023 | | 2023 |
| Therapeutic compositions and methods of using serotonin modulating microbiome-based interventions to treat serotonin-related diseases or disorders P STRANDWITZ, M CABONI, S Skolnick US Patent App. 17/621,767, 2022 | | 2022 |
Allan SaulDirector of GSK Vaccines Institute for Global HealthVerified email at gsk.com
